Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Stockfleth

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|March 7, 2017
The importance of treating the field in actinic keratosisE Stockfleth
Journal of the European Academy of Dermatology and Venereology : JEADV|December 4, 2014
Lmax and imiquimod 3.75%: the new standard in AK managementE Stockfleth
Journal of the European Academy of Dermatology and Venereology : JEADV|December 4, 2014
From a new vision of actinic keratosis to imiquimod 3.75%, the new treatment standard. IntroductionE Stockfleth
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|September 17, 2009
Topical management of actinic keratosis and field cancerisationE Stockfleth
Journal of the European Academy of Dermatology and Venereology : JEADV|March 26, 2018
Actinic keratoses seldom occur aloneL Schmitz, E Stockfleth
Journal of the European Academy of Dermatology and Venereology : JEADV|June 23, 2022
Encouraging sun protection early in life: from a successful prevention programme in children to the identification of psychological barriers in adolescentsE Stockfleth, O Revol
The Journal of Dermatological Treatment|October 3, 2003
Current treatment patterns in non-melanoma skin cancer across EuropeT Schmook, E Stockfleth
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 25, 2002
New treatment modalities for basal cell carcinomaE Stockfleth, W Sterry
Actas Dermo-Sifiliograficas|January 26, 2010
Field treatment of actinic keratoses - focus on COX-2-inhibitorsM Ulrich, E Stockfleth
The British Journal of Dermatology|May 10, 2007
Does progression from actinic keratosis and Bowen's disease end with treatment: diclofenac 3% gel, an old drug in a new environment?M J Patel, E Stockfleth
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Journal of the European Academy of Dermatology and Venereology : JEADV|March 7, 2017
The importance of treating the field in actinic keratosisE Stockfleth
Journal of the European Academy of Dermatology and Venereology : JEADV|December 4, 2014
Lmax and imiquimod 3.75%: the new standard in AK managementE Stockfleth
Journal of the European Academy of Dermatology and Venereology : JEADV|December 4, 2014
From a new vision of actinic keratosis to imiquimod 3.75%, the new treatment standard. IntroductionE Stockfleth
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|September 17, 2009
Topical management of actinic keratosis and field cancerisationE Stockfleth
Journal of the European Academy of Dermatology and Venereology : JEADV|March 26, 2018
Actinic keratoses seldom occur aloneL Schmitz, E Stockfleth
Journal of the European Academy of Dermatology and Venereology : JEADV|June 23, 2022
Encouraging sun protection early in life: from a successful prevention programme in children to the identification of psychological barriers in adolescentsE Stockfleth, O Revol
The Journal of Dermatological Treatment|October 3, 2003
Current treatment patterns in non-melanoma skin cancer across EuropeT Schmook, E Stockfleth
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 25, 2002
New treatment modalities for basal cell carcinomaE Stockfleth, W Sterry
Actas Dermo-Sifiliograficas|January 26, 2010
Field treatment of actinic keratoses - focus on COX-2-inhibitorsM Ulrich, E Stockfleth
The British Journal of Dermatology|May 10, 2007
Does progression from actinic keratosis and Bowen's disease end with treatment: diclofenac 3% gel, an old drug in a new environment?M J Patel, E Stockfleth
Pageof 16